These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9265351)

  • 21. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
    Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
    Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
    Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combined radiotherapy of uveal melanoma].
    Brovkina AF; Kesheleva VV; Fridman FE; Fishkin IG
    Vestn Oftalmol; 1997; 113(2):10-2. PubMed ID: 9229894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanoma.
    Marconi DG; de Castro DG; Rebouças LM; Bernardes Gil GO; Fogaroli RC; Conte Maia MA; Gobo Silva ML; Assis Pellizzon AC; Motono Chojniak MM
    Brachytherapy; 2013; 12(3):235-9. PubMed ID: 22436517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Optimizing target volume assessment in irradiation of intraocular melanomas with ruthenium applicators].
    Poier E; Langmann G; Leitner H; Vidic B
    Fortschr Ophthalmol; 1991; 88(2):158-60. PubMed ID: 1855736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ruthenium plaque radiation for iris and iridociliary melanomas: development of dry eyes?
    Razzaq L; de Keizer RJ
    Br J Ophthalmol; 2010 Nov; 94(11):1549-50. PubMed ID: 20516146
    [No Abstract]   [Full Text] [Related]  

  • 27. [Impression cytology of the conjunctiva following high-dose brachytherapy of malignant melanoma of the uvea using 106Ru/106Rh applicators].
    Koch JM; Bornfeld N; Waubke TN; Wessing A
    Fortschr Ophthalmol; 1988; 85(6):642-5. PubMed ID: 3220378
    [No Abstract]   [Full Text] [Related]  

  • 28. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The potential for organ-preserving treatment in large uveal melanoma].
    Terent'eva LS; Fokin VP
    Oftalmol Zh; 1989; (6):338-41. PubMed ID: 2622597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: a mono-institutional experience.
    Perri P; Fiorica F; D'Angelo S; Lamberti G; Parmeggiani F; Martini A; Carpenteri F; Colosimo C; Micucci M; Perazzini L; De Gugliemo E; Berretta M; Sebastiani A; Cartei F
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1919-24. PubMed ID: 23242717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radiation optic neuropathy after the brachytherapy of the uveal melanoma].
    Szuścik I; Romanowska-Dixon B; Markiewicz A; Pogrzebielski A; Jakubowska B
    Klin Oczna; 2006; 108(7-9):278-80. PubMed ID: 17290823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: evaluation of 175 patients treated with 150 Gy from 1981-1989.
    Pötter R; Janssen K; Prott FJ; Widder J; Haverkamp U; Busse H; Müller RP
    Front Radiat Ther Oncol; 1997; 30():143-9. PubMed ID: 9205894
    [No Abstract]   [Full Text] [Related]  

  • 33. Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients.
    Finger PT; Chin KJ; Duvall G;
    Ophthalmology; 2009 Apr; 116(4):790-6, 796.e1. PubMed ID: 19243829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
    Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
    Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The analysis of I125 brachytherapy complications in cases of uveal melanoma].
    Pogrzebielski A; Starzycka M; Romanowska-Dixon B; Jakubowska B; Szpakowicz U
    Klin Oczna; 2005; 107(1-3):49-53. PubMed ID: 16052800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corneoscleral necrosis after episcleral Au-198 brachytherapy of uveal melanoma.
    Chaudhry IA; Liu M; Shamsi FA; Arat YO; Shetlar DJ; Boniuk M
    Retina; 2009 Jan; 29(1):73-9. PubMed ID: 18728617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does the imaging method have an influence on the measured tumor height in ruthenium plaque therapy of uveal melanoma?
    Schueller P; Dogan A; Panke JE; Micke O; Willich N
    Strahlenther Onkol; 2005 May; 181(5):320-5. PubMed ID: 15900429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ruthenium-106 brachytherapy.
    Pe'er J
    Dev Ophthalmol; 2012; 49():27-40. PubMed ID: 22042011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7-year study.
    Finger PT; Berson A; Szechter A
    Ophthalmology; 1999 Mar; 106(3):606-13. PubMed ID: 10080222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.